Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

The recruitment status of this study is unknown because the information has not been verified recently.

Verified August 2005 by East Valley Hematology and Oncology Medical Group.
Recruitment status was Recruiting

Study NCT00131313 Information provided by East Valley Hematology and Oncology Medical Group

First Received on August 16, 2005. Last Updated on August 17, 2005 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Cyclophosphamide
Pentostatin
Rituximab

More general drug interventions related to this trial

Sponsors listed in this trial